SEELOS THERAPEUTICS INC's ticker is SEEL and the CUSIP is 81577F109. A total of 86 filers reported holding SEELOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.70 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $165,558 | -86.5% | 899,773 | -12.3% | 0.00% | -100.0% |
| Q2 2023 | $1,226,056 | +22.9% | 1,025,988 | -28.9% | 0.00% | +50.0% |
| Q1 2023 | $997,719 | +19.2% | 1,443,459 | +17.1% | 0.00% | 0.0% |
| Q4 2022 | $836,842 | -53.8% | 1,232,463 | -30.0% | 0.00% | -60.0% |
| Q3 2022 | $1,813,000 | +3.4% | 1,760,614 | -31.7% | 0.01% | +25.0% |
| Q2 2022 | $1,754,000 | -45.9% | 2,578,143 | -33.4% | 0.00% | +33.3% |
| Q1 2022 | $3,242,000 | +40.3% | 3,869,128 | +173.0% | 0.00% | -40.0% |
| Q4 2021 | $2,310,000 | -34.3% | 1,417,041 | -2.9% | 0.01% | -44.4% |
| Q3 2021 | $3,518,000 | -9.3% | 1,459,894 | -0.6% | 0.01% | -18.2% |
| Q2 2021 | $3,878,000 | -58.9% | 1,468,770 | -22.3% | 0.01% | -66.7% |
| Q1 2021 | $9,433,000 | – | 1,890,402 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Uniplan Investment Counsel, Inc. | 2,033,020 | $1,904,000 | 0.13% |
| 1492 Capital Management LLC | 150,000 | $141,000 | 0.11% |
| Spark Investment Management LLC | 13,100 | $12,000 | 0.02% |
| ARDSLEY ADVISORY PARTNERS LP | 80,000 | $75,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,437 | $26,000 | 0.00% |
| WealthPLAN Partners, LLC | 20,000 | $18,000 | 0.00% |
| CIBC WORLD MARKET INC. | 500,000 | $468,000 | 0.00% |
| CAPITAL COUNSEL LLC/NY | 10,000 | $9,000 | 0.00% |
| J.W. COLE ADVISORS, INC. | 10,000 | $9,000 | 0.00% |
| Renaissance Technologies | 591,086 | $554,000 | 0.00% |